Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Kidney Cancer|Lung Cancer
Interventions: BIOLOGICAL: interleukin-4 PE38KDEL cytotoxin
Sponsor: Neurocrine Biosciences